In contrast, BofA Securities downgraded Zai Lab from Buy to Neutral, though it raised the price target from $29 to $36.10. BofA maintained its 2025-26 revenue estimates but increased its revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback